Israeli venture capital's proud parent

Ed Mlavsky, one of the founder fathers of Israel's venture capital industry, tells "Globes" that there were "good teachers, who taught us the wrong things."

After more than 16 years in Israeli venture capital, and 13 years at the Israel-United States Binational Industrial Research and Development Foundation (BIRD-F) fund, Ed Mlavsky (81) has already seen it all.

When he was at BIRD-F, terms like "venture capital" and "exit" were foreign to Israel's economic reality. He was among the few who knew how the industry really works. He understood what an influx of money in return for shares could do for the Israel high-tech industry, and to what extent big money can change the picture.

With these insights, Mlavsky was a partner in the idea to set up the government Yozma fund, and he founded Gemini Israel Funds, the first venture capital fund, together with Yossi Sela.

With this background, in addition to his British manners and sense of humor, which he still retains after 30 years in Israel, Mlavsky has his own elegant way of delivering criticism, including that of the industry which he helped found.

"People don't understand what a technology powerhouse Israel has become," he says in a special interview with "Globes", on the occasion of his receipt of the lifetime achievement award from the Israel Management Center (IMC). "However," he adds, "we have to become expert here in how to bring the product to customers who are on the other end of the world.

"Solving this problem became a substantial matter and we made many mistakes getting there. One of the results is that companies here are sold much too quickly."

Globes: Wait, isn't that your fault - the fund and the industry?

Mlavsky: "We share the blame, yes. But it is not really our fault. Venture capital funds are not a homogeneous creature. Every fund is in a different place, and has a different point of view. In the end, we want a successful exit and sometimes it's worth waiting and not rushing to sell."

After all the years in the industry, Mlavsky's range of associations is wide, and so every discussion turns into a series of stories, some known, some less so. In this case, in order to demonstrate that it is not always the fund that pushes for an exit, Mlavsky pulls out the story of Traiana, one of Gemini's portfolio companies, that was sold in October, 2007, to ICAP.

It turns out that in 2006, the company, received a purchase offer for $30 million, and founder Gil Mandelzis thought to sell. "We told him that it pays to wait, and 18 months later we sold it for $250 million. There have been cases where we told founders, 'why are your rushing?'"

"There are a number of rules that you learn about how to manage venture capital. At Gemini, we learned them from Advent (a US private equity firm which set up the fund together with Sela and Mlavsky), and half of them were nonsense.

"They say, for example, that when you are raising money, it always goes to the company and not to private people, founders or investors. Yes, that is an excellent idea, but only as long as you are willing to break it, such as, for example, when you are about to lose the founder of the company and sell it for a fraction of what you could have received."

Mlavsky is quick to pull out a graph of the US venture capital association, the NVCA, which shows that 92% of a company's growth is after a public offering. "Besides that, from a national perspective, to sell fast is a bad thing", he continues. "I would prefer to see more Israeli public companies buying more Israeli start-ups. We don’t need to sell these companies to somebody else."

Here he cites the example of Orbot and Optrotech, which were direct competitors in the printed circuit board inspection industry, and merged in 1992 to form Orbotech Ltd. (Nasdaq: ORBK). "They were forced to merge and it was a bloodbath, but a world leader in the industry was formed," relates Mlavsky.

"We did some things correctly then, and some things not," he confesses. "We had to learn. Believe me, we had good teachers, who taught us the wrong things. The immediate response is that when a company is sold too quickly, it's because of the funds.

"Sometimes that is correct. If a fund is in the final stages of its life, and investors want to raise a new fund, and you have to show results, they will try to sell, and that is different from a fund which is starting out. Israel's reputation as a place of technological abilities arose to a large extent thanks to the funds. Could they have done a better job? Certainly. But we couldn't have done it without them."

Published by Globes [online], Israel business news - www.globes-online.com - on February 4, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010

Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Record public company profits  credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Advs. Roy Keidar and Netanella Treistman credit: Nicky Westphal AI blind spot startups can no longer afford to ignore

How AI governance can assist startups and enhance their ability to succeed.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Donald Trump speaking on the deck of the USS Gerald R. Ford  at its launch in 2017 credit: Reuters/Jonathan Ernst Houthis between hammer and anvil

President Trump appears determined to end the Houthi threat to shipping, while Iran has abandoned the last active arm of its "axis of resistance."

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

Dop Elbit banner at London's Allianz HQ credit: Reuters PA Images Violence against Israeli defense cos in UK escalates

"The Sunday Times" has investigated Palestine Action, a radical left-wing group that targets Israeli defense companies, their subsidiaries, and corporations and banks with any connection to Israel.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018